Announcing BixBench: A Benchmark to Evaluate AI Agents on Bioinformatics Tasks

Today, in partnership with ScienceMachine, FutureHouse is introducing BixBench, a benchmark designed to evaluate AI agents on real-world bioinformatics tasks. BixBench challenges AI models with open-ended analytical research scenarios, requiring them to analyze data, generate insights, and interpret results autonomously.

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.

Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.

Biocair Announces Further Expansion in the APAC Region As Part of Global Growth Strategy

Biocair, an established global leader in life science logistics, announces the expansion of its operations with the opening of a new office in Chengdu, Sichuan Province, China.

eClinical Solutions Details Strong 2024 and Announces New Products Aimed at Reducing Cycle Times for Biopharma

Company prioritizes efficiency through innovation with new embedded AI and automation platform capabilities, including a GenAI-Powered Chatbot and Clean Progress Tracking

Vector Laboratories Announces the Appointment of Ashley Scholz as Vice President of Marketing

Vector Laboratories has appointed Ashley Scholz as its new Vice President of Marketing. Ashley brings 16+ years of experience in medical devices, cancer diagnostics, and molecular diagnostics, most recently leading marketing at W.L. Gore & Associates.

Oxford Nanopore expands compatibility with 10x Genomics to unlock deeper insights in single-cell transcriptomics

Oxford Nanopore has expanded its collaboration with 10x Genomics to help improve single-cell transcriptomics research.

Sphere Fluidics rebrands to Sphere Bio

Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions.

Qureight core imaging platform deployed within Vicore Phase 2b ASPIRE study of buloxibutid for IPF

Qureight Ltd and Vicore Pharma today announce the implementation of Qureight’s Core Imaging Platform within the global Phase 2b ASPIRE trial investigating buloxibutid in patients with idiopathic pulmonary fibrosis (IPF).

VECTOR LABORATORIES ANNOUNCES PARTNERSHIP WITH BRITISH BIOTECH INNOVATOR ETCEMBLY

Vector Laboratories and Etcembly announce a collaboration to accelerate recombinant antibody therapeutic development. The collaboration combines Vector’s antibody expertise with AI-driven insights from Etcembly’s award-nominated platform.

Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategic Growth

ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health

ClearNote Health announced New York State has approved its Avantect Pancreatic Cancer Test. The ClearNote Health Laboratory now has its NYSDOH permit, as well as its CLIA certification and CAP accreditation.

ResultsCX Rises to ‘Innovator’ Status in Avasant’s CX Center Business Process Transformation RadarView™ Assessment

Cleveland Clinic Announces the Rollout of Ambience Healthcare’s AI Platform

CluePoints named as Finalist in 2025 ACDM Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.

Sapio Sciences Expands Leadership Team to Drive Growth

Sapio Sciences today announced key leadership appointments to accelerate drug discovery and redefine AI-driven lab informatics. With the appointment of Mike Hampton as Chief Commercial Officer (CCO) and the launch of a new Scientific Office, Sapio is reinforcing its commitment to scientific and customer-driven innovation.

Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston April 3, 2025 with Expanded AI Focus

The second annual Bio-IT World Venture, Innovation & Partnering Conference, taking place April 3 in Boston, will bring together 200+ venture capitalists, private equity professionals, bankers, government partners, and entrepreneurs who are advancing the growth of the TechBio, biotech, drug discovery and healthcare sectors.

Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform

Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.

JuliaHub Doubles Investment in Advanced Pharmaceutical Modeling Platform

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform.

Pillar VC Expands into UK and Launches Encode, an AI for Science Fellowship

Backed by Pillar VC and powered by the Advanced Research + Invention Agency, the Encode Fellowship will place top AI talent in leading UK research labs to accelerate scientific breakthroughs